AVTX $0.00 ( +0.00%) Quote details

stock

Avalo Therapeutics Inc

NASDAQ | AVTX

4.78

USD

+0.00 ( +0.00%)

AT CLOSE (AS OF Jun 27, 2025)

$52M

MARKET CAP

0.0402

P/E Ratio

118.98

EPS

$16

52 Week High

$3.4

52 Week Low

LIFE SCIENCES

Sector

AVTX Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

AVTX Technicals

Tags:

AVTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $807K
Total Revenue $441K
Cost Of Revenue -$366K
Costof Goods And Services Sold -$366K
Operating Income -$69M
Selling General And Administrative $16M
Research And Development $52M
Operating Expenses $69M
Investment Income Net -
Net Interest Income $3.3M
Interest Income -
Interest Expense $3.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $169K
Income Before Tax -$35M
Income Tax Expense $114K
Interest And Debt Expense -
Net Income From Continuing Operations -$35M
Comprehensive Income Net Of Tax -
Ebit -$69M
Ebitda -$68M
Net Income -$35M

Revenue & Profitability

Earnings Performance

AVTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $151M
Total Current Assets $139M
Cash And Cash Equivalents At Carrying Value $135M
Cash And Short Term Investments $135M
Inventory -
Current Net Receivables $611K
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill $11M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.7M
Other Non Current Assets -
Total Liabilities $18M
Total Current Liabilities $7M
Current Accounts Payable $283K
Deferred Revenue -
Current Debt -
Short Term Debt $568K
Total Non Current Liabilities $11M
Capital Lease Obligations $568K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $568K
Other Current Liabilities $6.7M
Other Non Current Liabilities $2.4M
Total Shareholder Equity $133M
Treasury Stock -
Retained Earnings -$370M
Common Stock $10K
Common Stock Shares Outstanding $11M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$49M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $169K
Capital Expenditures $0
Change In Receivables -
Change In Inventory $0
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $176M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $68K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$35M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $807K
Total Revenue $441K
Cost Of Revenue -$366K
Costof Goods And Services Sold -$366K
Operating Income -$69M
Selling General And Administrative $16M
Research And Development $52M
Operating Expenses $69M
Investment Income Net -
Net Interest Income $3.3M
Interest Income -
Interest Expense $3.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $169K
Income Before Tax -$35M
Income Tax Expense $114K
Interest And Debt Expense -
Net Income From Continuing Operations -$35M
Comprehensive Income Net Of Tax -
Ebit -$69M
Ebitda -$68M
Net Income -$35M

AVTX News

AVTX Profile

Avalo Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

None

GVH
-25.49%
$0.133
NVDA
1.76%
$157.75
HCTI
-12.83%
$0.0231
PLTR
-9.37%
$130.74
LCID
-3.64%
$2.12
F
1.60%
$10.8
AUR
-4.26%
$5.17
OST
-36.42%
$0.3497
DNN
-2.72%
$1.79
AMZN
2.85%
$223.3
NKE
15.19%
$72.04
QS
-13.46%
$6.62
GOOGL
2.88%
$178.53
INTC
0.84%
$22.69
LCFY
225.49%
$8.3
SOFI
2.44%
$17.18
TSLA
-0.66%
$323.63
WBD
1.35%
$11.3
HIMS
6.76%
$49.41
RCT
126.26%
$3.24
RKLB
-2.10%
$35.38
GOOG
2.20%
$178.27
CIFR
1.67%
$4.26
AAPL
0.04%
$201.08
CORZ
1.77%
$16.65
NCNA
4.00%
$0.0859
AXDX
-61.36%
$0.034
CHPT
-2.01%
$0.7366
VALE
2.85%
$9.74
CLOV
-1.08%
$2.76
NIO
1.17%
$3.46
SNAP
7.13%
$8.72
BTG
-3.29%
$3.53
QBTS
-0.28%
$14.02
AMD
0.09%
$143.81
ACHR
-1.13%
$10.47
PLUG
-4.92%
$1.16
MRK
0.34%
$79.1
INMB
-15.13%
$5.33
URG
-6.54%
$1.05
BAC
-0.72%
$47.12
QXO
-4.56%
$20.73
RIOT
0.38%
$10.55
WULF
-3.87%
$4.22
LYT
-16.78%
$0.0982
SMCI
-3.43%
$47.58
BTBT
1.00%
$2.01
RGTI
-0.36%
$11.07
CCO
0.84%
$1.2
GRAB
5.35%
$4.92
JWN
0.08%
$24.66
APLD
-1.70%
$10.38
VOR
19.10%
$1.06
OCGN
-4.46%
$0.9841
CRCL
-15.54%
$180.43
CCL
4.17%
$27.26
RXRX
-6.85%
$5.03
SVRE
38.70%
$3.19
OKLO
-1.06%
$55.26
AAL
1.35%
$11.28
QUBT
2.98%
$17.29
EOSE
-2.86%
$4.41
LUMN
3.68%
$4.51
PRMB
0.93%
$29.35
AMIX
60.80%
$2.01
JOBY
-0.42%
$9.44
EAF
-4.50%
$1.06
MARA
-1.57%
$15.03
PFE
-0.21%
$24.19
MVST
3.06%
$4.04
GENI
0.19%
$10.38
ABEV
-0.42%
$2.36
ATUS
0.47%
$2.13
SOUN
-0.91%
$9.83
IREN
6.79%
$14
AU
-5.35%
$43.88
T
0.29%
$28.08
CLF
-0.40%
$7.42
NAOV
34.62%
$1.17
HOOD
-1.76%
$83.03
MU
-0.98%
$124.76
HBAN
-0.24%
$16.6
GEVO
-3.03%
$1.28
RZLV
-7.12%
$2.74
CPNG
3.35%
$30.81
MSFT
-0.30%
$495.94
INSM
-2.21%
$99.49
KHC
-0.70%
$25.61
SISI
-1.30%
$0.2132
BTE
-0.54%
$1.83
ASTS
-2.49%
$49.36
RIG
-1.90%
$2.58
BFLY
-2.97%
$1.96
WMT
1.30%
$97.27
DFS
-0.21%
$200.05
PCG
-0.64%
$13.99
FLEX
-0.40%
$49.89
STLA
2.62%
$10.19
HPP
1.12%
$2.71
BB
-3.81%
$4.54
GVH
-25.49%
$0.133
NVDA
1.76%
$157.75
HCTI
-12.83%
$0.0231
PLTR
-9.37%
$130.74
LCID
-3.64%
$2.12
F
1.60%
$10.8
AUR
-4.26%
$5.17
OST
-36.42%
$0.3497
DNN
-2.72%
$1.79
AMZN
2.85%
$223.3
NKE
15.19%
$72.04
QS
-13.46%
$6.62
GOOGL
2.88%
$178.53
INTC
0.84%
$22.69
LCFY
225.49%
$8.3
SOFI
2.44%
$17.18
TSLA
-0.66%
$323.63
WBD
1.35%
$11.3
HIMS
6.76%
$49.41
RCT
126.26%
$3.24
RKLB
-2.10%
$35.38
GOOG
2.20%
$178.27
CIFR
1.67%
$4.26
AAPL
0.04%
$201.08
CORZ
1.77%
$16.65
NCNA
4.00%
$0.0859
AXDX
-61.36%
$0.034
CHPT
-2.01%
$0.7366
VALE
2.85%
$9.74
CLOV
-1.08%
$2.76
NIO
1.17%
$3.46
SNAP
7.13%
$8.72
BTG
-3.29%
$3.53
QBTS
-0.28%
$14.02
AMD
0.09%
$143.81
ACHR
-1.13%
$10.47
PLUG
-4.92%
$1.16
MRK
0.34%
$79.1
INMB
-15.13%
$5.33
URG
-6.54%
$1.05
BAC
-0.72%
$47.12
QXO
-4.56%
$20.73
RIOT
0.38%
$10.55
WULF
-3.87%
$4.22
LYT
-16.78%
$0.0982
SMCI
-3.43%
$47.58
BTBT
1.00%
$2.01
RGTI
-0.36%
$11.07
CCO
0.84%
$1.2
GRAB
5.35%
$4.92
JWN
0.08%
$24.66
APLD
-1.70%
$10.38
VOR
19.10%
$1.06
OCGN
-4.46%
$0.9841
CRCL
-15.54%
$180.43
CCL
4.17%
$27.26
RXRX
-6.85%
$5.03
SVRE
38.70%
$3.19
OKLO
-1.06%
$55.26
AAL
1.35%
$11.28
QUBT
2.98%
$17.29
EOSE
-2.86%
$4.41
LUMN
3.68%
$4.51
PRMB
0.93%
$29.35
AMIX
60.80%
$2.01
JOBY
-0.42%
$9.44
EAF
-4.50%
$1.06
MARA
-1.57%
$15.03
PFE
-0.21%
$24.19
MVST
3.06%
$4.04
GENI
0.19%
$10.38
ABEV
-0.42%
$2.36
ATUS
0.47%
$2.13
SOUN
-0.91%
$9.83
IREN
6.79%
$14
AU
-5.35%
$43.88
T
0.29%
$28.08
CLF
-0.40%
$7.42
NAOV
34.62%
$1.17
HOOD
-1.76%
$83.03
MU
-0.98%
$124.76
HBAN
-0.24%
$16.6
GEVO
-3.03%
$1.28
RZLV
-7.12%
$2.74
CPNG
3.35%
$30.81
MSFT
-0.30%
$495.94
INSM
-2.21%
$99.49
KHC
-0.70%
$25.61
SISI
-1.30%
$0.2132
BTE
-0.54%
$1.83
ASTS
-2.49%
$49.36
RIG
-1.90%
$2.58
BFLY
-2.97%
$1.96
WMT
1.30%
$97.27
DFS
-0.21%
$200.05
PCG
-0.64%
$13.99
FLEX
-0.40%
$49.89
STLA
2.62%
$10.19
HPP
1.12%
$2.71
BB
-3.81%
$4.54
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.